- Home
- COMM vs SPRY Comparison
COMM vs SPRY Comparison
Compare COMM & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COMM
- SPRY
- Stock Information
- Founded
- COMM 1976
- SPRY 2015
- Country
- COMM United States
- SPRY United States
- Employees
- COMM N/A
- SPRY N/A
- Industry
- COMM Radio And Television Broadcasting And Communications Equipment
- SPRY Biotechnology: Pharmaceutical Preparations
- Sector
- COMM Technology
- SPRY Health Care
- Exchange
- COMM Nasdaq
- SPRY Nasdaq
- Market Cap
- COMM 1.3B
- SPRY 1.6B
- IPO Year
- COMM 2013
- SPRY N/A
- Fundamental
- Price
- COMM $8.67
- SPRY $16.95
- Analyst Decision
- COMM Hold
- SPRY Strong Buy
- Analyst Count
- COMM 4
- SPRY 4
- Target Price
- COMM $4.88
- SPRY $28.75
- AVG Volume (30 Days)
- COMM 5.7M
- SPRY 1.5M
- Earning Date
- COMM 08-07-2025
- SPRY 08-05-2025
- Dividend Yield
- COMM N/A
- SPRY N/A
- EPS Growth
- COMM N/A
- SPRY N/A
- EPS
- COMM 3.42
- SPRY N/A
- Revenue
- COMM $4,417,100,000.00
- SPRY $97,122,000.00
- Revenue This Year
- COMM $21.50
- SPRY N/A
- Revenue Next Year
- COMM $8.30
- SPRY $140.40
- P/E Ratio
- COMM $2.54
- SPRY N/A
- Revenue Growth
- COMM 16.19
- SPRY 971120.00
- 52 Week Low
- COMM $1.05
- SPRY $8.77
- 52 Week High
- COMM $8.67
- SPRY $18.90
- Technical
- Relative Strength Index (RSI)
- COMM 80.64
- SPRY 55.33
- Support Level
- COMM $7.91
- SPRY $15.75
- Resistance Level
- COMM $8.58
- SPRY $18.90
- Average True Range (ATR)
- COMM 0.41
- SPRY 1.04
- MACD
- COMM 0.18
- SPRY 0.01
- Stochastic Oscillator
- COMM 100.00
- SPRY 49.26
About COMM CommScope Holding Company Inc.
CommScope Holding Co Inc is a provider of infrastructure solutions for communication, data center, and entertainment networks. The company provides solutions for wired and wireless networks to enable service providers, including cable, telephone, data center, and digital broadcast satellite operators and media programmers, to deliver media, voice, Internet Protocol (IP) data services, and Wi-Fi to their subscribers and allow enterprises to experience constant wireless and wired connectivity across complex and varied networking environments. The company's operating segments are: Connectivity and Cable Solutions (CCS), Networking, Intelligent Cellular and Security Solutions (NICS), and Access Network Solutions (ANS).
About SPRY ARS Pharmaceuticals Inc.
ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.